Photon Therapy Versus Proton Therapy in Early Tonsil Cancer.

In this trial, patients with early squamous cell carcinoma of the tonsil with clinical stage T1-2 (p16-positive or p16-negative) N0-1 (p16-positive)/N0-N2b (p16-negative) according to American Joint Committee on Cancer (AJCC) 8th edition, aimed for unimodal and ipsilateral treatment with radiotherapy with curative intent will be included. The patients will be randomized to in a 1:1 ratio to receive radiotherapy with either photons (conventional radiotherapy) versus radiotherapy with protons.

Trial Details

NCT ID
NCT03829033
Phase
NA
Sponsor
Lund University Hospital
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Radiotherapy
Locations (sample)
  • Gävle, Sweden|60.67452,17.14174
  • Gothenburg, Sweden|57.70716,11.96679
  • Jönköping, Sweden|57.78145,14.15618
  • Karlstad, Sweden|59.3793,13.50357
  • Linköping, Sweden|58.41086,15.62157

Key Eligibility Criteria

  • The patient must be at least 18 years old.
  • Histologically or cytologically confirmed, previously untreated squamous cell carcinoma of the tonsil T1-2 (p16-positive or p16-negative) N0-1 M0 (…
  • World Health Organisation/Eastern Cooperative Oncology Group (WHO/ECOG) performance status 0-1.
  • The patient must be able to understand the information about the treatment and give a written informed consent.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →